CO169 Ensifentrine, an Investigational, Inhaled PDE3/4 Inhibitor, Decreased COPD-Related Healthcare Resource Utilization over 24 Weeks
Abstract
Authors
E. Wan K. Rickard A. Dixon J. Davidson S. Galloway T. Rheault
E. Wan K. Rickard A. Dixon J. Davidson S. Galloway T. Rheault
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now